Pioneering diagnostics

 Facts & Figures

bioMérieux provides diagnostic solutions (reagents, instruments, software and services) which determine the source of disease and contamination to improve patient health and ensure product safety.

What We Do

  • In clinical applications, the Company offers a wide range of solutions mainly for managing infectious diseases.
  • For the agri-food, cosmetics and pharmaceutical industries, bioMérieux provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing.

Our Assets

  • A strong commitment and a long-term vision (family-owned company).
  • World leader in clinical microbiology.
  • Leader in industrial microbiological control for the agri-food, cosmetics and pharmaceutical industries.
  • Leader in the syndromic molecular diagnosis of infectious diseases.
  • A broad international footprint.
  • Installed base of some 86,900 instruments worldwide (as of December 31, 2016).

Key Figures

  • € 2.103 billion in sales (as of Dec. 31, 2016)
  • 2 main applications:
    • Clinical Diagnostics: ~ 80% of sales,
    • Industrial Microbiology: ~ 18% of sales.
  • 9,800 employees (full-time equivalents) at the end of December 2016.
  • Present in more than 150 countries through 42 subsidiaries,
    • 90% of sales outside France.
  • 19 production sites (nearly 3,000 employees)
  • 20 R&D sites (1,600 employees)
  • bioMérieux is listed on NYSE Euronext Paris.